デフォルト表紙
市場調査レポート
商品コード
1008084

肛門および大腸癌の世界市場予測(2020年~2026年)

Global Anal & Colorectal Cancer Market 2020-2026

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
肛門および大腸癌の世界市場予測(2020年~2026年)
出版日: 2021年04月23日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の肛門および大腸癌の市場規模は、予測期間中にかなりのCAGRで拡大すると予想されています。大腸癌は、肛門癌の場合、肛門で発生する間に結腸または直腸の細胞で発生する悪性腫瘍です。肥満やたばこの消費などの不健康なライフスタイルによる肛門癌および大腸癌の有病率の上昇は、その治療に対する需要を生み出し、それが今度は市場成長を推進しています。大腸癌は、世界で3番目に多い悪性腫瘍であり、癌関連の死亡の4番目に多い原因です。世界保健機関(WHO)によると、2020年には、すべての年齢の男性と女性の大腸癌の死亡者数は、世界中で約935,173人であり、これは総死者数の9.4%です。さらに、2020年のすべての年齢の男女の新規の大腸癌患者数は世界で約190万人であり、これは新規癌症例の10.0%です。

米国癌協会によると、2021年に米国で約9,090の新しい肛門癌の症例が予想されており、そのうち女性が6,070人、男性が3,020人です。さらに、2021年には約1,430人が肛門癌で死亡する見通しです。それとは別に、2021年には約104,270人の大腸癌と約45,230人の直腸癌が新たに発生すると予想されています。大腸癌への影響は、市場成長を促進するもう1つの要因です。ただし、このタイプの癌に対する意識の低さと肛門および大腸癌治療の高コストは、市場成長の主要な制約として機能します。しかし、ヘルスケア費の増加、癌治療の技術的進歩、および肛門および大腸癌治療の需要の高まりは、特に新興諸国で市場を牽引すると予想されます。

当レポートでは、世界の肛門および大腸癌市場について調査分析し、市場概要、市場決定要因、市場区分、競合情勢、地域別分析、主要企業などについて、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向

第3章 競合情勢

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最新動向
  • 主要な戦略分析

第4章 市場の決定要因

  • 成長要因
  • 抑制要因
  • 市場機会

第5章 市場セグメンテーション

  • 治療タイプ別市場
    • 放射線治療
    • 化学療法
    • 標的療法
    • 免疫療法
  • エンドユーザー別市場
    • 病院
    • 外来手術センター
    • 癌調査センター

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • その他の地域

第7章 企業プロファイル

  • Advaxis, Inc.
  • Amgen Inc.
  • Atara Biotherapeutics, Inc.
  • Bayer AG
  • Beckman Coulter, Inc.
  • Boehringer Ingelheim International GmbH
  • Clinical Genomics Technologies Pvt. Ltd.
  • EDP Biotech Corp.
  • Eli Lilly and Co.
  • Exact Sciences Corp.
  • Genomictree Co., Ltd.
  • IMV Inc.
  • ISA Pharmaceuticals B.V.
  • Merck & Co., Inc.
  • Metabiomics Corp.
  • 小野薬品工業
  • ORYX GmbH & Co. KG,
  • Quest Diagnostics Inc.,
  • Randox Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Siemens AG
  • 大鵬薬品工業
  • Taiwan Liposome Co, Ltd.
  • VolitionRX Ltd.
図表

LIST OF TABLES

  • 1. GLOBAL ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL RADIATION THERAPY FOR ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL CHEMOTHERAPY ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 5. GLOBAL TARGETED THERAPY ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 6. GLOBAL IMMUNOTHERAPY ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 8. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 9. GLOBAL AMBULATORY SURGERY CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 10. GLOBAL CANCER RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 11. GLOBAL ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS REGION, 2019-2026 ($ MILLION)
  • 12. NORTH AMERICAN ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 13. NORTH AMERICAN ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 14. NORTH AMERICAN ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
  • 15. EUROPEAN ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 16. EUROPEAN ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 17. EUROPEAN ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
  • 18. ASIA-PACIFIC ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 19. ASIA-PACIFIC ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 20. ASIA-PACIFIC ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
  • 21. REST OF THE WORLD ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 22. REST OF THE WORLD ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ANAL & COLORECTAL CANCER MARKET SHARE BY END-USER, 2019 VS 2026 (%)
  • 2. GLOBAL ANAL & COLORECTAL CANCER MARKET SHARE BY TREATMENT TYPE, 2019 VS 2026 (%)
  • 3. GLOBAL ANAL & COLORECTAL CANCER MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 4. GLOBAL RADIATION THERAPY FOR ANAL & COLORECTAL MARKET SHARE BY REGION, 2019 VS 2026 (%)
  • 5. GLOBAL CHEMOTHERAPY IN ANAL & COLORECTAL MARKET SHARE BY REGION, 2019 VS 2026 (%)
  • 6. GLOBAL TARGETED THERAPY IN ANAL & COLORECTAL MARKET SHARE BY REGION, 2019 VS 2026 (%)
  • 7. GLOBAL IMMUNOTHERAPHY IN ANAL & COLORECTAL MARKET SHARE BY REGION, 2019 VS 2026 (%)
  • 8. GLOBAL HOSPITALS SEGMENT IN ANAL & COLORECTAL MARKET SHARE BY REGION, 2019 VS 2026 (%)
  • 9. GLOBAL AMBULATORY SURGERY CENTRES SEGMENT IN ANAL & COLORECTAL MARKET SHARE BY REGION, 2019 VS 2026 (%)
  • 10. GLOBAL CANCER RESEARCH CENTERS IN ANAL & COLORECTAL MARKET SHARE BY REGION, 2019 VS 2026 (%)
  • 11. US ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. CANADA ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. UK ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. FRANCE ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. GERMANY ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. ITALY ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 17. SPAIN ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 18. REST OF EUROPE ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 19. INDIA ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 20. CHINA ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 21. JAPAN ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 22. SOUTH KOREA ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 23. REST OF ASIA-PACIFIC ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 24. REST OF THE WORLD ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
目次
Product Code: OMR2023377

Global Anal & Colorectal Cancer Market Size, Share & Trends Analysis Report by Treatment (Radiation Therapy, Chemotherapy, Targeted Therapy, and Immunotherapy), By End-User (Hospitals, Ambulatory Surgery Centers, and Cancer Research Centers) Forecast Period 2020-2026

The global anal & colorectal cancer market is anticipated to grow at a considerable CAGR during the forecast period. Colorectal cancer is a malignant tumor that starts in the cells of the colon or the rectum while it takes place in the anus in case of anal cancer. The rising prevalence of anal and colorectal cancer due to poor lifestyles such as obesity and tobacco consumption has created a demand for its treatment which, in turn, is driving the market growth. Colorectal cancer is the third most common malignancy and the fourth leading cause of cancer-related mortalities globally. As per the World Health Organization (WHO), in 2020, the number of colorectum cancer of mortality of male and female of all ages was around 935,173 across the globe, which is 9.4% of total mortalities. Additionally, the number of new colorectum cancer patients of both sexes of all ages in 2020 was around 1.9 million globally, which is 10.0% of new cancer cases.

As per the American Cancer Society, around 9,090 new cases of anal cancer are expected in the US in 2021, of which 6,070 in women and 3,020 in men. Besides, around 1,430 mortalities of anal cancer are expected in 2021. Apart from it, around 104,270 new cases of colon cancer and around 45,230 new cases of rectal cancer are expected in the US in 2021. Furthermore, the increasing geriatric population which is more prone to colorectal cancer is another factor driving the market growth. However, the high cost of anal and colorectal cancer treatment along with low awareness towards this type of cancer act as major restraints for the market growth. However, increasing healthcare expenditure, technological advancement for cancer treatment, and rising demand for anal and colorectal cancer treatment are expected to drive the market especially in developing countries.

Segmental Outlook

The global anal and colorectal cancer market is segmented based on treatment and end-user. Based on the treatment, the market is segmented into radiation therapy, chemotherapy, targeted therapy, and immunotherapy. Based on end-users the market is segmented into hospitals, ambulatory surgery centers, and cancer research centers. Hospitals held a major market share in 2019 based on end-user. The factors such as rising quality assessment in hospitals, growing colorectal cancer cases among individuals, and increasing demand for minimal complication rates in surgery of special colorectal cancer are anticipating driving the growth of this market segment.

Regional Outlooks

The global anal & colorectal cancer market is further segmented based on geography into North America, Europe, Asia-Pacific, and the Rest of the World. North America has been predicted to dominate the global anal & colorectal cancer market. The high prevalence of anal & colorectal cancer cases in the US along with easy access of US citizens to its treatment due to the presence of well-established healthcare infrastructure is anticipated to drive the growth of this regional growth of market.

Global Anal & Colorectal Cancer Market Growth by Region, 2020-2026

Source: OMR Global

Asia-Pacific is Projected to Exhibit Considerable Growth in the Global Anal & Colorectal Cancer Market

Asia-Pacific is anticipated to exhibit considerable growth in the global anal & colorectal cancer market during the forecast period. The rising geriatric population which is prone to cancer coupled with the increasing incidence and prevalence rate of anal & colorectal cancer are the factors driving the regional growth of the market. As per the WHO, in 2020, in Asia-pacific, around 569,186 incidences of colon cancer were recorded, which is 49.6% of total cases across the globe. Besides, around 296,236 mortalities were recorded due to colon cancer in 2020, which was around 51.4%. Apart from this, the number of anal cancer patients in 2020 was 16,645, and mortalities were 8,120 in the region.

Market Players Outlook

Some of the key players of the anal & colorectal cancer market include Amgen Inc., Taiho Pharmaceutical Co., Ltd, F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market.

The Report Covers

  • Market value data analysis of 2019 and forecast to 2026.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global anal and colorectal cancer market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global ANAL & COLORECTAL Cancer Market by Treatment Type
    • 5.1.1. Radiation Therapy
    • 5.1.2. Chemotherapy
    • 5.1.3. Targeted Therapy
    • 5.1.4. Immunotherapy
  • 5.2. Global ANAL & COLORECTAL Cancer Market by End-User
    • 5.2.1. Hospitals
    • 5.2.2. Ambulatory Surgery Centers
    • 5.2.3. Cancer Research Centers

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Advaxis, Inc.
  • 7.2. Amgen Inc.
  • 7.3. Atara Biotherapeutics, Inc.
  • 7.4. Bayer AG
  • 7.5. Beckman Coulter, Inc.
  • 7.6. Boehringer Ingelheim International GmbH
  • 7.7. Clinical Genomics Technologies Pvt. Ltd.
  • 7.8. EDP Biotech Corp.
  • 7.9. Eli Lilly and Co.
  • 7.10. Exact Sciences Corp.
  • 7.11. Genomictree Co., Ltd.
  • 7.12. IMV Inc.
  • 7.13. ISA Pharmaceuticals B.V.
  • 7.14. Merck & Co., Inc.
  • 7.15. Metabiomics Corp.
  • 7.16. ONO Pharmaceutical Co., Ltd.
  • 7.17. ORYX GmbH & Co. KG,
  • 7.18. Quest Diagnostics Inc.,
  • 7.19. Randox Laboratories Ltd.
  • 7.20. F. Hoffmann-La Roche Ltd.
  • 7.21. Siemens AG
  • 7.22. Taiho Pharmaceutical Co., Ltd.
  • 7.23. Taiwan Liposome Co, Ltd.
  • 7.24. VolitionRX Ltd.